Macropinocytosis is a non‐selective endocytic uptake of adjacent materials and is hyperactivated in KRAS‐mutant cancer cells to meet their increased metabolic demands in nutrient‐scarce environments.[51] KRAS mutations, present in up to 95% of PDAC cases, are well‐established drivers of macropinocytosis. Here, KRAS is linked to cancer.